Predictive Factors of Pseudoprogression in Vestibular Schwannoma Treated with Fractionated Stereotactic Radiotherapy

被引:0
作者
Lo, A. W. S. [1 ]
Nyaw, S. F. [2 ]
Mui, W. H. [2 ]
Huang, J. J. [2 ]
Kam, K. M. [3 ]
Wong, C. S. [2 ]
机构
[1] Prince Wales Hosp, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[2] Tuen Mun Hosp, Dept Clin Oncol, Tuen Mun, Hong Kong, Peoples R China
[3] Hong Kong Sanat & Hosp, Comprehens Oncol Ctr, Happy Valley, Hong Kong, Peoples R China
来源
HONG KONG JOURNAL OF RADIOLOGY | 2019年 / 22卷 / 03期
关键词
Neuroma; acoustic; Radiotherapy; Risk factors; ACOUSTIC NEUROMAS; RADIOSURGERY; RADIATION; MANAGEMENT; EXPANSION; SURGERY;
D O I
10.12809/hkjr1916934
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Fractionated stereotactic radiotherapy (FSRT) is a well-established treatment for vestibular schwannoma (VS). Tumour pseudoprogression may lead to worsening symptoms leading to the necessity of urgent salvage surgery. This study aimed to assess the predictive factors of pseudoprogression and treatment related toxicities in VS treated with FSRT. Methods: This retrospective cohort study included all patients with VS treated with FSRT between 1999 and 2015. Risk factors assessed included sex, age, previous surgical resection, tumour diameter, gross tumour volume, planning target volume, overall treatment time, equivalent dose in 2-Gy fractions, and the presence of brainstem or cerebellar compression prior to radiotherapy. Fisher's exact test and two-sample t test were used for statistical analysis. Results: Eighteen patients were included. The median follow-up time was 80.3 months. The overall disease control rate after FSRT was 94.4%. Of the 18 patients, one (5.6%) developed local tumour progression, seven (38.9%) underwent tumour pseudoprogression; and 10 (55.6%) had stable disease. Median time to tumour pseudoprogression was 8.63 months (range, 4.5-13.1 months). Tumours with pseudoprogression and those with at least stable disease had a mean diameter of 2.7 cm and 2.1 cm, respectively (p = 0.18). The mean treatment planning target volume in the pseudoprogression group was larger than that in the non-progression group with volume measured (22.2 cc vs. 10.0 cc; p = 0.04). Patients with brainstem or cerebellar compression observed on magnetic resonance imaging before radiotherapy were associated with a higher risk of pseudoprogression (p = 0.0498). The overall salvage surgery rate was 17.7%. Conclusion: Upfront surgery may be more desirable than FSRT for those surgically fit patients with considerable treatment volume and evidence of mass effect. Large prospective studies are needed to confirm our findings and to identify further predictive factors for pseudoprogression.
引用
收藏
页码:152 / 159
页数:8
相关论文
共 50 条
  • [31] Vestibular Schwannoma Hypofractionated Stereotactic Radiation Therapy in Five Fractions
    Gawish, A.
    Walke, M.
    Roellich, B.
    Ochel, H. -J.
    Brunner, T. B.
    CLINICAL ONCOLOGY, 2023, 35 (01) : E40 - E47
  • [32] Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities
    Lo, Andrea
    Ayre, Gareth
    Ma, Roy
    Hsu, Fred
    Akagami, Ryojo
    McKenzie, Michael
    Valev, Boris
    Gete, Ermias
    Vallieres, Isabelle
    Nichol, Alan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (02): : 443 - 451
  • [33] Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Arteriovenous Malformation
    Da Roz, Leila Maria
    Mauro, Geovanne Pedro
    Gico, Vinicius de Carvalho
    Weltman, Eduardo
    de Souza, Evandro Cesar
    Figueiredo, Eberval Gadelha
    Teixeira, Manoel Jacobsen
    WORLD NEUROSURGERY, 2023, 176 : E415 - E419
  • [34] Malignancy in Vestibular Schwannoma after Stereotactic Radiotherapy: A Case Report and Review of the Literature
    Husseini, Sami Tanbouzi
    Piccirillo, Enrico
    Taibah, Abdelkader
    Paties, Carlo T.
    Rizzoli, Roberto
    Sanna, Mario
    LARYNGOSCOPE, 2011, 121 (05) : 923 - 928
  • [35] Unique case of malignant transformation of a vestibular schwannoma after fractionated radiotherapy
    Markou, Konstantinos
    Eimer, Sandrine
    Perret, Clotilde
    Huchet, Aymeri
    Goudakos, John
    Liguoro, Dominique
    Franco-Vidal, Valerie
    Maire, Jean-Philippe
    Darrouzet, Vincent
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (01) : 168 - 173
  • [36] Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: A preliminary report
    Poen, JC
    Golby, AJ
    Forster, KM
    Martin, DP
    Chinn, DM
    Hancock, SL
    Adler, JR
    NEUROSURGERY, 1999, 45 (06) : 1299 - 1305
  • [37] The Recent Management of Vestibular Schwannoma Radiotherapy: A Narrative Review of the Literature
    Brun, Lucie
    Mom, Thierry
    Guillemin, Florent
    Puechmaille, Mathilde
    Khalil, Toufic
    Biau, Julian
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (06)
  • [38] Vestibular schwannoma radiosurgery: progression or pseudoprogression? Response
    Link, Michael J.
    JOURNAL OF NEUROSURGERY, 2017, 127 (02) : 376 - 379
  • [39] Predictive Factors of Unfavorable Events After Gamma Knife Radiosurgery for Vestibular Schwannoma
    Kim, Ji Hee
    Jung, Hyun Ho
    Chang, Jong Hee
    Chang, Jin Woo
    Park, Yong Gou
    Chang, Won Seok
    WORLD NEUROSURGERY, 2017, 107 : 175 - 184
  • [40] Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: a Leksell Gamma Knife Society 2000 debate
    Linskey, ME
    JOURNAL OF NEUROSURGERY, 2000, 93 : 90 - 95